Africa: The CDC Has a New Director - Now Comes the Hard Part

What the report says

In an analysis published by The Conversation Africa and carried by AllAfrica on Aug. 19, 2026, writers Syra S. Madad and Nahid Bhadelia examined the confirmation of Erica Schwartz as the new director of the U.S. Centers for Disease Control and Prevention. Schwartz was confirmed by the U.S. Senate on Aug. 5, 2026, making her only the second CDC director to undergo Senate confirmation after Congress created the process in the post-COVID-19 period.

The article says the change was designed to increase scrutiny over a major public health post, but argues that confirmation alone cannot solve the CDC’s deeper challenges. The agency is currently dealing with measles outbreaks, a multistate cyclospora investigation tied to produce, and support for the Ebola response in Central Africa. The authors also note that federal childhood vaccine policy is being reshaped in a politically charged environment, raising concerns about scientific independence.

Schwartz, a retired U.S. Public Health Service rear admiral, previously served as chief medical officer with the Coast Guard and later as deputy surgeon general. The analysis emphasizes that the Senate hearing created a public record on vaccines, scientific integrity and political pressure, but that the harder task is whether Schwartz can use her authority while the CDC remains part of the Health and Human Services Department.

The piece adds broader context about staffing and resources, saying the CDC workforce has been reduced and that outbreak response depends on laboratories, epidemiologists, state partners and public trust. It concludes that congressional oversight may help, but lasting independence for the agency would require legal changes.